Miracell to Participate in AMWC (Asia World Congress of Aesthetic Anti-Aging) 2023
Stem cell extraction system ‘Smart Mcell’ receives favorable reviews [Edaily Reporter Lee Soon-yong] Stem cell specialist Miracell (CEO Shin Hyun-soon/Shin Nuri) announced on the 10th that it participated in the AMWC ASIA & TDAC (Aesthetic Medicine World Congress ASIA & Taiwan Dermatology Aesthetic Conference 2023), held at the Taipei Convention Center in Taiwan from the 5th to the 7th, and introduced its stem cell extraction system. AMWC ASIA is a forum where aesthetic medicine doctors and industry partners gather to share insights on the latest technologies and innovative products in the fields of aesthetics, anti-aging, and cosmetic surgery. The conference attracted approximately 2,600 medical professionals from Asia, including Taiwan, and over 130 medical companies, with approximately 200 speakers. At the conference, Miracell widely promoted the excellence of its proprietary stem cell extraction system, “SMART M-CELL,” and its kits. Stem cell extraction, isolation, and concentration are achieved within 17 minutes. These autologous stem cells are ready for immediate use, with a cell viability rate of up to 99%. From anti-aging skin care to preventive care, and the treatment of conditions such as acute myocardial infarction, cartilage defects, and critical limb ischemia,Miracell has received high praise from medical professionals around the world as a biosystem that meets the needs of anti-aging medicine. Miracell has secured the core stem cell technology through 21 domestic and international cell extraction technology patents. Through Smart M-Cell, Miracell has secured National Health Technology NET (New Technology Network) and Government Innovation Product certifications, and has completed FDA registration, leading the way in the advancement of stem cell therapy and advanced regenerative medicine. CEO Shin Hyun-soon stated, “There’s a growing interest in anti-aging regenerative medicine cell therapy. After seeing our products at international conferences,we’re seeing an increasing number of medical professionals and medical group buyers visiting Korea. They observe the entire process, from stem cell extraction to treatment,using SmartMcell, or verifying the effectiveness through cell counts. Many of these patients then undergo the treatment themselves, leading to contracts.” Miracell has participated in various international conferences, including those in Europe, the US, and the Middle East. Currently, it exports SmartMcell to 30 countries,and is enjoying a smooth run in the global market. Miracell also plans to participate in IMCAS Asia, held in Bangkok, Thailand, from June 9th, to promote SmartMcell. By Lee Soon-yong
[Press Release] KIMES 2023 Summary – A to Z Analysis
Under the theme of “Better Life, Better Future,”over 1,300 domestic and international companies participated, exhibiting and introducing over 35,000 items, including cutting-edge medical devices, hospital equipment, medical information systems, healthcare and rehabilitation devices, and medical supplies.The 38th Korea International Medical Equipment & Hospital Equipment Show (KIMES 2023) concluded successfully over four days. Based on numerous achievements, KIMES 2023 heralded a remarkable leap forward as a leading medical industry exhibition not only in Korea but also in Asia,and further elevated its status. To conclude, this year’s KIMES 2023, which drew the spotlight,our Medical Newspaper took a comprehensive look at the participating companies and the ins and outs of the event. Reporter Oh In-gyu 529@bosa.co.kr
[StemcellTV] With Dr. Stem Ep.4_The importance of Immunity
[StemcellTV] With Dr. Stem Ep.4_The importance of Immunity [StemcellTV] With Dr. Stem Ep.4_The importance of Immunity “Immunity is the best doctor and an cure – Hippocrates” Immunity can be divided into innate immunity, which is present from birth and acquired immunity, which is obtained through adaptation through acquired life. The word we call ‘immunity’ actually refers to this acquired immunity. The immune system is built to defend the body against dangerous invaders. “Immunity is the best doctor and an cure – Hippocrates” Immunity can be divided into innate immunity, which is present from birth and acquired immunity, which is obtained through adaptation through acquired life. The word we call ‘immunity’ actually refers to this acquired immunity. The immune system is built to defend the body against dangerous invaders. https://www.youtube.com/watch?v=Q3GpW5g_SgI List
[StemcellTV] With Dr. Stem Ep.3_Types of Stemcells!
[StemcellTV] With Dr. Stem Ep.3_Types of Stemcells! [StemcellTV] With Dr. Stem Ep.3_Types of Stemcells! Hello. This is Dr. Stem from MIRACELL. I will enrich your knowledge with stem cell-related information in an easy-to-understand manner. Have you guessed what the answer to the above question is? Cells are the answer! Hello. This is Dr. Stem from MIRACELL. I will enrich your knowledge with stem cell-related information in an easy-to-understand manner. Have you guessed what the answer to the above question is? Cells are the answer! https://youtu.be/MsIxAfx7awQ List
[StemcellTV] With Dr. Stem Ep.2_Everything about Blood vassels!
[StemcellTV] With Dr. Stem Ep.2_Everything about Blood vassels! [StemcellTV] With Dr. Stem Ep.2_Everything about Blood vassels! Do you know what the longest road in our body is? If you connect all of them in a row, it is about 100,000 km. That’s enough to circle the Earth two and a half times. What on earth is that? The answer is blood vessels. Hello. This is Dr. Stem from MIRACELL. I will enrich your knowledge with stem cell-related information Do you know what the longest road in our body is? If you connect all of them in a row, it is about 100,000 km. That’s enough to circle the Earth two and a half times. What on earth is that? The answer is blood vessels. Hello. This is Dr. Stem from MIRACELL. I will enrich your knowledge with stem cell-related information https://youtu.be/LAxWa3UYhro List
Miracell to Participate in IMCAS 2023 in France, Introducing Smart M-Cell
Miracell to Participate in IMCAS 2023 in France, Introducing Smart M-Cell Miracell announced its participation in the ‘IMCAS World Congress 2023,’ the world’s largest international conference on aesthetic surgery, held in Paris, France. This year’s ‘IMCAS 2023’ brought together prominent speakers from 137 countries to share cutting-edge technologies, ideas, and surgical knowledge in the fields of plastic surgery and dermatology, with a total of 14,000 attendees. At the conference, Miracell introduced its ‘SMART M-CELL 2’ and widely promoted its domestic stem cell extraction system technology. Smart M-CELL 2 is a system that extracts, separates, and concentrates stem cells and is already being used for regenerative treatments and procedures in hospitals and clinics both domestically and internationally. Meanwhile, Miracell plans to present its technology at the American Academy of Orthopedic Surgeons (AAOS) Annual Meeting in Las Vegas, USA, from March 8th to 10th. Reporter Jeong Ui-jun firstay@sedaily.com
[StemcellTV] With Dr. Stem Ep.1_Stop the blood! I’m a Platelet!
[StemcellTV] With Dr. Stem Ep.1_Stop the blood! I’m a Platelet! [StemcellTV] With Dr. Stem Ep.1_Stop the blood! I’m a Platelet! With Miracell’s mascot, Dr. Stem, we’re going to learn a lot about stem cells. The first video that I’m going to show you is “platelet.” Platelet counts are an important health indicator for the human body. Also, platelets, which have recently been suggested to play an important role in congenital immunity! With Miracell’s mascot, Dr. Stem, we’re going to learn a lot about stem cells. The first video that I’m going to show you is “platelet.” Platelet counts are an important health indicator for the human body. Also, platelets, which have recently been suggested to play an important role in congenital immunity! https://youtu.be/aObkTWcTi7k List
Miracell Participates in Medica, the World’s Largest Medical Device Exhibition in Germany
Miracell Participates in Germany’s Medica, the World’s Largest Medical Device Exhibition Targeting the Global Market with the Stem Cell Extraction System “Smart Mcell 2” [Edaily Reporter Lee Soon-yong] Stem cell specialist Miracell (CEO Shin Hyun-soon) announced on the 16th that it is participating in “MEDICA 2022,” the world’s largest medical device exhibition, held in Düsseldorf, Germany, until the 17th. MEDICA is an international trade fair encompassing the global medical technology industry, and has been held annually since 1969. This event is expected to attract over 4,400 companies from approximately 70 countries, and over 150,000 visitors from 150 countries are expected. “MEDICA 2022” showcased a wide range of medical technologies, including the latest medical equipment and systems, laboratory technology equipment, diagnostic imaging, robotics, and advanced medical solutions and health IT applications. At this exhibition, Miracell showcased the excellence of its stem cell extraction system, “SMART M-CELL2,” and its dedicated kits (SMART M-CELL2 and Kits) to medical professionals from around the world. “SMART M-CELL2” is a cutting-edge bio-device that supports effective cell therapy, providing cells optimized for tissue regeneration and core biological cells that serve as a rich source of protein. The patented separation technology reduces granular leukocytes and produces more monocytes, thereby reducing inflammation and increasing the proportion of stem cells. Miracell is already conducting several clinical trials with general and university hospitals in Korea, and its effectiveness in stem cell regeneration therapy is highly recognized. Shin Hyun-soon, CEO of Miracell, said, “We are participating in MEDICA again in 2021 to expand our presence in the European market. Given the importance of a strong platform for international exchange and business in the medical technology industry, we are actively targeting overseas markets to promote Korea’s outstanding technology and our cutting-edge bio stem cell extraction system.” “Given the strong buyer interest in regenerative medicine, we plan to expand our global exports with the upgraded SmartMcell 4, following the SmartMcell 2.” Meanwhile, Miracell plans to attend the ‘IMCAS World Congress 2023,’ the world’s largest aesthetic plastic surgery conference, to be held in Paris in January next year.
Miracell to Unveil Automated Stem Cell Extraction System at KIMES BUSAN 2022… “High Cell Survival Rate!”
Miracell to Unveil Automated Stem Cell Extraction System at KIMES Busan 2022… “High Cell Survival Rate!” Miracell (CEO Shin Hyun-soon) will showcase its automated stem cell extraction system at the 2022 Busan Medical Equipment Exhibition (KIMES BUSAN 2022), held at BEXCO Exhibition Center 2 in Busan from Friday, October 28th to Sunday, October 30th. Miracell, which began its medical business in 1986, has dedicated itself to stem cell research and development since 2009, establishing itself as a stem cell specialist. Miracell’s biological drug manufacturing technology was directly registered as a new medical technology for treating conditions such as acute myocardial infarction (2014), critical limb ischemia (2013), and cartilage defects (2012),and was certified by the Korea Food and Drug Administration (KFDA) and the Ministry of Health and Welfare in 2014. This cutting-edge cell extraction system can extract large quantities of stem cells through selective isolation and concentration from blood and bone marrow.The company has received the National Health Technology NET (No. 179) certification for its “Smart M-Cell 2” and has been selected by the government as a “National Innovative Company.”It has been selected as a leading company in the healthcare and diagnostics sector. Recently registered with the FDA,it has secured core technologies through GMP, ISO13485, ISO9001, and CE European Union standard certifications, and 22 patent applications for cell extraction technology. The “Smart M-Cell 2” automated stem cell extraction system can selectively isolate, extract, and concentrate stem cells in just 17 minutes. Its key technology maximizes cell viability. It automatically adjusts the RPM and angle of the separation vessel and reduces friction between vessels to minimize cell damage. This bio-digital device utilizes a closed system that prevents air contact and is equipped with LEDs that stimulate cell activation.Furthermore, because it utilizes autologous bone marrow or blood, it is safe from immune rejection and side effects.It is used in hospitals and clinics nationwide, including university hospitals. A Miracell representative explained, “We are leading the popularization of the stem cell market with Smart Mcell 2, a cutting-edge bio-regenerative medical device developed with our own technology based on years of accumulated expertise. We hope that KIMES BUSAN 2022 will lead to contracts with numerous hospitals and clinics, and provide an opportunity to widely publicize the effectiveness of Miracell’s unique technology and stem cell treatments both domestically and internationally.” They continued, “Through membership in the Cellpia Global Platform (CGP), we have built an organic network with doctors and medical staff at hospitals and clinics in Korea and abroad, sharing specialized stem cell medical technology. CGP provides education, technology transfer, medical system setup, and marketing to ensure safe stem cell regenerative medicine treatments for hospitals both domestically and internationally.” Meanwhile, KIMES BUSAN 2022, a regional medical industry exhibition centered around Busan, encompassing Daegu, Ulsan, North Gyeongsang Province, and South Gyeongsang Province, provides an opportunity to experience next-generation medical devices and healthcare products tailored to the future healthcare market. With the consumption and demand for smartphone healthcare content and smart wearable devices rapidly increasing and competition among related companies intensifying, KIMES BUSAN 2022 will showcase and introduce diverse forms of smart healthcare products and services evolving through big data, the Internet of Things (IoT), biotechnology (BT), and information and communications technology (ICT). Source: AVING (http://kr.aving.net)
[NEWS]Miracell announces psoriasis case cured with stem cell therapy
Miracell announces psoriasis case cured with stem cell therapy South Korean stem cell research company Miracell said Friday it had publishedthe clinical trial results of a new regenerative skin stem cell therapy at a recentconference hosted by the International Society for Aesthetic Plastic Surgery held in Bangkok. The clinical trial was conducted on a patient with psoriasis, a skin disease that isgenerally treated with steroids, but has a tendency to recur over time. The patient was found to have completed recovered after receiving intravenousinjections with bone marrow stem cells and cells extracted from blood twice. The treatment uses Miracell’s stem cell extraction system “Smart Emcell2,”and bone marrow and blood kits devised by the company. “The patient was suffering from psoriasis for six years, having difficulties in leadinga normal life due to the severity of the symptoms. But the patient could recoverafter being treated with the stem cell therapy,” said professor Park Eun-soo,one of the researchers who led the clinical trial. Miracell CEO Shin Hyun-soon said the trial results could be successful due to theuse of fresh cells with a survival rate of up to 99 percent. “By developing better products, we will continue to try to give hope tosuffering patients around the world.” ▶https://www.koreaherald.com/view.php?ud=20221021000543&ACE_SEARCH=1